Immunology/Inflammation
Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
- 5-Lipoxygenase(11)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(12)
- IκB/IKK(67)
- AP-1(6)
- KEAP1-Nrf2(65)
- NOD1(1)
- TLR(140)
- NF-κB(241)
- Interleukin Related(171)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(36)
- CD73(14)
- Complement System(58)
- Galectin(12)
- IFNAR(25)
- NO Synthase(77)
- NOD-like Receptor (NLR)(51)
- STING(110)
- Reactive Oxygen Species(465)
- Apoptosis(802)
- FKBP(20)
- eNOS(5)
- iNOS(29)
- nNOS(20)
- Glutathione(57)
- Adaptive Immunity(222)
- Allergy(130)
- Arthritis(34)
- Autoimmunity(190)
- Gastric Disease(101)
- Immunosuppressants(39)
- Immunotherapeutics(5)
- Innate Immunity(593)
- Pulmonary Diseases(119)
- Reactive Nitrogen Species(55)
- Reactive Sulfur Species(28)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- BCL6(3)
- CD20(3)
- CD22
- CD28(1)
- FAP(7)
- PSMA(7)
- Nuclear Factor of activated T Cells (NFAT)(1)
- Glycoprotein VI(1)
- Tim3(2)
- Hapten(1)
- Nectin-4(2)
Immunology/Inflammation 相关产品(4245)
- GC66356CusatuzumabCAS: 1864871-20-4纯度: >95.00%
Cusatuzumab 是一种人 αCD70 单克隆抗体。 Cusatuzumab 显示出增强抗体依赖性的细胞毒性。 Cusatuzumab 可减少白血病干细胞 (LSC) 并触发与骨髓分化和凋亡 apoptosis 相关的基因特征。Cusatuzumab 具有研究急性白血病 (AML) 的潜力。
- GC66363Randialic acid BCAS: 14021-14-8纯度: >99.00%
Randialic acid B 是一种三萜化合物,是一种甲酰肽受体 1 (FPR1) 拮抗剂。Randialic acid B 阻断人中性粒细胞中的 FPR1 并在体内减轻银屑病样炎症。
- GC66392PROTAC STING Degrader-1CAS: 2762552-74-7纯度: >98.00%
PROTAC STING Degrader-1 (Compound SP23) 是一种 STING PROTAC 降解剂,其 DC50 为 3.2 μM。PROTAC STING Degrader-1 具有抗炎活性。
- GC66396AgatolimodCAS: 525625-52-9纯度: >96.00% / >98.00%
Agatolimod (ODN 2006) 为 B 类 ODN (寡脱氧核苷酸),是一种 TLR9 激动剂。Agatolimod 也是人类最优的 CpG 序列。Agatolimod 刺激 HD11 细胞产生 NO2 和 IL-6。Agatolimod 可用于乳腺癌研究。序列:5'-tcgtcgttttgtcgttttgtcgtt-3'。
- GC66410CemdisiranCAS: 1639264-46-2纯度: >96.00%
Cemdisiran是一种 GalNAc 偶联的 siRNA干扰,通过抑制肝脏补体5 (C5)蛋白的产生来治疗补体介导的疾病。
- GC66485Bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] oxalateCAS: 30431-54-0
Bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] oxalate 是一种活性较高的过草酸酯,可用于荧光染料检测H2O2。
- GC66824D-α-Tocopherol SuccinateCAS: 4345-03-3
D-α-Tocopherol Succinate (Vitamin E succinate) 是一种抗氧化生育酚,是维生素 E 的一种盐形式。D-α-Tocopherol Succinat 抑制 Cisplatin 引起的毒性。D-α-Tocopherol Succinate 可用于癌症的研究。
- GC66870β-D-GlucanCAS: 9041-22-9纯度: >95.00%
β-D-glucan 是一种天然的不易消化的多糖,具有很高的生物相容性,可被识别受体,如 Dectin-1 和 Toll 样受体选择性识别,并容易被鼠或人巨噬细胞内化。β-D-glucan 是益生菌的肠道输送载体。
- GC66874N-((Allyloxy)carbonyl)-N-methyl-L-alanineCAS: 918531-01-8
N-((Allyloxy)carbonyl)-N-methyl-L-alanine 是一种丙氨酸衍生物。N-((Allyloxy)carbonyl)-N-methyl-L-alanine 可用于合成补体因子D (complement factor D) 抑制剂。补体因子 D 抑制剂可用于免疫系统相关疾病的研究。
- GC67191(±)-α-Tocopherol nicotinateCAS: 51898-34-1
(±)-α-Tocopherol nicotinate,维生素 E-烟酸酯,是一种具有口服活性的脂溶性抗氧化剂,能够防止细胞膜脂质过氧化。(±)-α-Tocopherol nicotinate 在血液中可水解为 α -生育酚和烟酸,可用于相关血管疾病的研究。
- GC67214Emoxypine succinateCAS: 127464-43-1纯度: >97.00%
Emoxypine succinate 是一种抗氧化剂。 Emoxypine succinate 可用于创伤后的研究。
- GC67272N6-BenzyladenosineCAS: 4294-16-0纯度: >98.00%
DNPH1i (N6-benzyladenosine,BAPR) is a competitive inhibitor of adenosine deaminase(ADA) from L-1210 cells in axenic culture as well as a potent antiproliferative agent in vitro and in vivo.
- GC67618α-Tocopherol phosphate disodiumCAS: 60934-46-5
α-Tocopherol phosphate disodium是一种水溶性的α-生育酚。α-Tocopherol phosphate disodium可通过清除活性氧抑制和调节基因表达发挥功能。
- GC676282',7'-DichlorofluoresceinCAS: 76-54-0纯度: >98.00%
2',7'-Dichlorofluorescein是一种荧光探针,可用于测量活性氧 (ROS) (Ex=496 nm 和 Em=525 nm)。
- GC67699TLR8 agonist 5CAS: 2413016-41-6纯度: >96.00%
TLR8 agonist 5 是有效的 TLR8 激动剂,对 HEK-Blue hTLR8 的 EC50 值为 20 nM。TLR8 agonist 5 激活免疫反应。
- GC67748BrodalumabCAS: 1174395-19-7纯度: >97.00%
Brodalumab (AMG 827) 是一种抗人白介素 17 受体 (IL-17R) IgG2 单克隆抗体,可用于研究中重度斑块性银屑病和类风湿性关节炎。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC66356 | Cusatuzumab | 1864871-20-4 | >95.00% | |
Cusatuzumab 是一种人 αCD70 单克隆抗体。 Cusatuzumab 显示出增强抗体依赖性的细胞毒性。 Cusatuzumab 可减少白血病干细胞 (LSC) 并触发与骨髓分化和凋亡 apoptosis 相关的基因特征。Cusatuzumab 具有研究急性白血病 (AML) 的潜力。 | ||||
| GC66363 | Randialic acid B | 14021-14-8 | >99.00% | |
Randialic acid B 是一种三萜化合物,是一种甲酰肽受体 1 (FPR1) 拮抗剂。Randialic acid B 阻断人中性粒细胞中的 FPR1 并在体内减轻银屑病样炎症。 | ||||
| GC66370 | Zapalog | 1708091-24-0 | - | |
Zapalog 是一种光可裂解的小分子异二聚体,可用于重复启动和瞬间终止两种靶蛋白之间的物理相互作用。 Zapalog 对用 FKBP 和 DHFR 结构域标记的任何两种蛋白质进行二聚化,直到暴露于光下导致其光解。 | ||||
| GC66392 | PROTAC STING Degrader-1 | 2762552-74-7 | >98.00% | |
PROTAC STING Degrader-1 (Compound SP23) 是一种 STING PROTAC 降解剂,其 DC50 为 3.2 μM。PROTAC STING Degrader-1 具有抗炎活性。 | ||||
| GC66393 | ODN 1018 | 937402-51-2 | >97.00% | |
ODN 1018 (1018 ISS) 是一种寡脱氧核苷酸,是一种 TLR-9 激动剂。 ODN 1018 也是一种合成的免疫刺激序列,可用作疫苗佐剂。序列:5′-TGACTGTGAACGTTCGAGATGA-3′。 | ||||
| GC66396 | Agatolimod | 525625-52-9 | >96.00% / >98.00% | |
Agatolimod (ODN 2006) 为 B 类 ODN (寡脱氧核苷酸),是一种 TLR9 激动剂。Agatolimod 也是人类最优的 CpG 序列。Agatolimod 刺激 HD11 细胞产生 NO2 和 IL-6。Agatolimod 可用于乳腺癌研究。序列:5'-tcgtcgttttgtcgttttgtcgtt-3'。 | ||||
| GC66407 | Etokimab | 2022981-44-6 | >99.00% | |
Etokimab (Antibody ANB 020) 是一种靶向 IL-33 的人源化单克隆抗体。Etokimab 可用于特应性皮炎的研究。 | ||||
| GC66410 | Cemdisiran | 1639264-46-2 | >96.00% | |
Cemdisiran是一种 GalNAc 偶联的 siRNA干扰,通过抑制肝脏补体5 (C5)蛋白的产生来治疗补体介导的疾病。 | ||||
| GC66414 | Sarilumab | - | >98.00% | |
Sarilumab (anti-IL-6Rα) is a fully human anti-IL-6Rα mAb that binds membrane-bound and soluble human IL-6Rα with high affinity, MW: 144.13 KD. | ||||
| GC66462 | MGH-CP1 | 896657-58-2 | >99.00% | |
MGH-CP1 is a potent and selective inhibitor of transcriptional enhanced associate domain (TEAD) palmitoylation. MGH-CP1 exhibits dose-dependent and potent inhibition of TEAD2/4 auto-palmitoylation in vitro with IC50 of 710 nM and 672 nM, respectively. | ||||
| GC66478 | LHC-165 | 1258595-14-0 | >98.00% | |
LHC-165 是一种有效的 Toll 样受体 7 (TLR7)) 激动剂。LHC-165 有研究实体肿瘤的潜力。 | ||||
| GC66485 | Bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] oxalate | 30431-54-0 | - | |
Bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] oxalate 是一种活性较高的过草酸酯,可用于荧光染料检测H2O2。 | ||||
| GC66824 | D-α-Tocopherol Succinate | 4345-03-3 | - | |
D-α-Tocopherol Succinate (Vitamin E succinate) 是一种抗氧化生育酚,是维生素 E 的一种盐形式。D-α-Tocopherol Succinat 抑制 Cisplatin 引起的毒性。D-α-Tocopherol Succinate 可用于癌症的研究。 | ||||
| GC66870 | β-D-Glucan | 9041-22-9 | >95.00% | |
β-D-glucan 是一种天然的不易消化的多糖,具有很高的生物相容性,可被识别受体,如 Dectin-1 和 Toll 样受体选择性识别,并容易被鼠或人巨噬细胞内化。β-D-glucan 是益生菌的肠道输送载体。 | ||||
| GC66874 | N-((Allyloxy)carbonyl)-N-methyl-L-alanine | 918531-01-8 | - | |
N-((Allyloxy)carbonyl)-N-methyl-L-alanine 是一种丙氨酸衍生物。N-((Allyloxy)carbonyl)-N-methyl-L-alanine 可用于合成补体因子D (complement factor D) 抑制剂。补体因子 D 抑制剂可用于免疫系统相关疾病的研究。 | ||||
| GC67191 | (±)-α-Tocopherol nicotinate | 51898-34-1 | - | |
(±)-α-Tocopherol nicotinate,维生素 E-烟酸酯,是一种具有口服活性的脂溶性抗氧化剂,能够防止细胞膜脂质过氧化。(±)-α-Tocopherol nicotinate 在血液中可水解为 α -生育酚和烟酸,可用于相关血管疾病的研究。 | ||||
| GC67214 | Emoxypine succinate | 127464-43-1 | >97.00% | |
Emoxypine succinate 是一种抗氧化剂。 Emoxypine succinate 可用于创伤后的研究。 | ||||
| GC67272 | N6-Benzyladenosine | 4294-16-0 | >98.00% | |
DNPH1i (N6-benzyladenosine,BAPR) is a competitive inhibitor of adenosine deaminase(ADA) from L-1210 cells in axenic culture as well as a potent antiproliferative agent in vitro and in vivo. | ||||
| GC67618 | α-Tocopherol phosphate disodium | 60934-46-5 | - | |
α-Tocopherol phosphate disodium是一种水溶性的α-生育酚。α-Tocopherol phosphate disodium可通过清除活性氧抑制和调节基因表达发挥功能。 | ||||
| GC67628 | 2',7'-Dichlorofluorescein | 76-54-0 | >98.00% | |
2',7'-Dichlorofluorescein是一种荧光探针,可用于测量活性氧 (ROS) (Ex=496 nm 和 Em=525 nm)。 | ||||
| GC67699 | TLR8 agonist 5 | 2413016-41-6 | >96.00% | |
TLR8 agonist 5 是有效的 TLR8 激动剂,对 HEK-Blue hTLR8 的 EC50 值为 20 nM。TLR8 agonist 5 激活免疫反应。 | ||||
| GC67719 | SN-001 | 727699-84-5 | - | |
SN-001 是一种 STING 抑制剂,IC50 为 3.82 μM。 | ||||
| GC67721 | CP-447697 | 1092847-21-6 | - | |
CP-447697 是亲脂性的 C5a 受体拮抗剂,IC50 值为 31 nM。CP-447697 可用于炎症的研究。 | ||||
| GC67748 | Brodalumab | 1174395-19-7 | >97.00% | |
Brodalumab (AMG 827) 是一种抗人白介素 17 受体 (IL-17R) IgG2 单克隆抗体,可用于研究中重度斑块性银屑病和类风湿性关节炎。 | ||||
